<!doctype html>
<html lang="en" manifest="cache.manifest">
  <head>
    <!-- Global site tag (gtag.js) - Google Analytics -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-E7V5SQE1XT"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-E7V5SQE1XT');
    </script>

    <link rel="manifest" href="manifest.json">
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <!-- Bootstrap CSS -->
    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@100;200;300;400;500;600;700;800;900&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <link rel="stylesheet" href="css/style.css">

    <title>Agios</title>
  </head>
  <body>
    <nav class="navbar navbar-expand-lg navbar-dark">
      <div class="container">
        <a class="navbar-brand" href="index.html">
          <img src="images/logo.png" />
        </a>

        <ul class="navbar-nav ml-auto">
            <li class="nav-item active">
              <a class="nav-link" href="index.html">
                <img src="images/icons/home-icon.png" width="30">
              </a>
            </li>
            <li class="nav-item active">
              <a class="nav-link" href="peak-registry.html">
                <img src="images/icons/peak-registry-icon.png" width="30">
              </a>
            </li>
            <li class="nav-item active">
              <a class="nav-link" href="pkr-activator-pipeline.html">
                <img src="images/icons/pipeline-icon.png" width="30">
              </a>
            </li>
          </ul>
      </div>
    </nav>
    <main class="pipeline-details">
      <div class="container" style="min-height: 930px;">
        <div class="row">
          <div class="col-sm-9 col-7">
            <h1 class="mb-4">DRIVE-PK Efficacy Outcomes</h1>
            <h4>Secondary endpoint</h4>
          </div>
          <div class="col-sm-3 col-5">
            <span class="badge blue-dark float-right mt-1">STATUS: CORE STUDY <strong><i>COMPLETED</i></strong><br/>EXTENSION ONGOING</span>
          </div>

          <div class="col-md-12">
            <div class="text-center mt-5">
              <div class="row">
                <div class="col-sm-4 mb-5">
                  <img src="images/drive-pk-efficacy-outcomes-1.png" class="mb-4" height="200" />
                  <h6>26/52 (50%) patients achieved a<br/> <strong>hemoglobin increase > 1 g/dL</strong><br/> during the 24-week core period</h6>
                </div>
                <div class="col-sm-4 mb-5">
                  <img src="images/drive-pk-efficacy-outcomes-2.png" class="mb-4" height="200" />
                  <h6>20 (77%) of these 26 patients had a<br/>
                  <strong>hemoglobin increase > 1 g/dL for<br/>
                  > 50% of assessments</strong> in the core period<br/>
                  (hemoglobin responders)</h6>
                </div>
                <div class="col-sm-4 mb-5">
                  <img src="images/drive-pk-efficacy-outcomes-3.png" class="mb-4" height="200" />
                  <h6>The <strong>overall hemoglobin<br/>
                  responder rate<sup>a</sup></strong> was 20/52 (38%)<br/>
                  patients (95% CI: 25%, 53%)</h6>
                </div>
              </div>
              <div class="row mb-4">
                <div class="col-sm-1"></div>
                <div class="col-sm-10">
                  <h6>All patients who had an average hemoglobin increase from baseline of > 1.0 g/dL had at least 1 missense <i>PKLR</i> mutation<sup>1</sup></h6>
                  <hr style="border-top: 2px solid rgb(69 165 211);" />
                  <h6>Improvements in hemoglobin and other markers of hemolysis achieved during the core period were sustained during the extension period (up to 42 months)<sup>2</sup></h6>
                </div>
              </div>
            </div>

            <div class="text-right mb-5">
              <a class="btn btn-outline-primary" href="drive-pk-safety-outcomes.html"><img src="images/icons/arrow-left.png" class="arrow-left" /> SAFETY</a>
            </div>
          </div>

        </div>
        <footer>
            <div class="row">
              <div class="col-md-7">
                <p class="text-left mb-4">
                <sup>a</sup>Hemoglobin responder rate is defined as the number of patients who had an increase of more than 1 g/dL in hemoglobin level in more than 50% of assessments during the core period.<br/>
                CI = confidence interval.<br/>
                <strong>1.</strong> Grace RF et al. <i>NEJM</i> 2019; 381:933-44; as of 31 August 2018.
                <strong>2.</strong> Grace RF et al. ASH 2019; Post 3512; as of 27 March 2019.</p>
              </div>
              <div class="col-md-5">
                <p class="text-right">For additional details, search ClinicalTrials.gov for<br/>
                NCT02476916 or EudraCT for 2015-000484-13.<br/>
                For more information (physician/HCP only),<br/>
                please email medinfo@agios.com.<br/>
                Â©2021 Agios Pharmaceuticals, Inc. All rights reserved.</p>
              </div>
            </div>
        </footer>
      </div>
    </main>
    <div class="screensaverDiv d-none">
      <img src="images/screensaver.gif" class="screensaverImg" />
    </div>

    <!-- Optional JavaScript -->
    <!-- jQuery first, then Popper.js, then Bootstrap JS -->
    <!-- <script src="https://code.jquery.com/jquery-3.2.1.slim.min.js" integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.12.9/umd/popper.min.js" integrity="sha384-ApNbgh9B+Y1QKtv3Rn7W3mgPxhU9K/ScQsAP7hUibX39j7fakFPskvXusvfa0b4Q" crossorigin="anonymous"></script> -->
    <script src="js/jquery-3.4.1.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
    <script src="js/screensaver.js"></script>
  </body>
</html>